How have DMK shares performed in 2023?

DMK Pharmaceuticals' stock was trading at $0.6655 on January 1st, 2023. Since then, DMK stock has decreased by 14.7% and is now trading at $0.5677. View the best growth stocks for 2023 here .

When is DMK Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024. View our DMK earnings forecast .

How do I buy shares of DMK Pharmaceuticals?

Shares of DMK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

DMK Pharmaceuticals Stock Price, News & Analysis (NASDAQ:DMK)

$0.57

+0.03 (+5.58%)

(As of 12/1/2023 ET)

Compare

Today's Range: $0.50
▼
$0.57
50-Day Range: $0.48
▼
$0.77
52-Week Range: $0.45
▼
$21.70

Volume: 125,040 shs
Average Volume: 122,174 shs
Market Capitalization: $5.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials Headlines SEC Filings Social Media

About DMK Pharmaceuticals Stock (NASDAQ:DMK)

DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company's lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was formerly known as Adamis Pharmaceuticals Corporation and changed its name to DMK Pharmaceuticals Corporation in September 2023. The company is headquartered in San Diego, California.

DMK Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DMK Stock News Headlines

December 1, 2023 | usatoday.com

Arizona attorney general sues pharmaceutical manufacturers for insulin price inflation scheme

November 28, 2023 | finanznachrichten.de

DMK Pharmaceuticals Corporation: DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI and Provides Corporate Update

December 2, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 28, 2023 | finance.yahoo.com

DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update

November 25, 2023 | ca.finance.yahoo.com

Arcimoto, Inc. (FUV)

November 24, 2023 | americanbankingnews.com

DMK Pharmaceuticals (NASDAQ:DMK) Trading 2.1% Higher

November 21, 2023 | morningstar.com

DMK Pharmaceuticals Corp

November 14, 2023 | finanznachrichten.de

DMK Pharmaceuticals Corporation: DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

December 2, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 14, 2023 | sfgate.com

DMK Pharmaceuticals: Q3 Earnings Snapshot

November 14, 2023 | msn.com

DMK Pharmaceuticals GAAP EPS of -$0.20

November 14, 2023 | finance.yahoo.com

DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 13, 2023 | finance.yahoo.com

DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023

October 21, 2023 | finanznachrichten.de

DMK Pharmaceuticals Corporation: DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)

October 20, 2023 | finance.yahoo.com

DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)

October 20, 2023 | finanznachrichten.de

DMK Pharmaceuticals Corporation: DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth

October 19, 2023 | marketwatch.com

DMK Pharmaceuticals Names Seth Cohen as Finance Chief

October 19, 2023 | msn.com

DMK Pharmaceuticals appoints Seth Cohen as CFO, succeeding David Marguglio

October 19, 2023 | finance.yahoo.com

DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth

September 28, 2023 | wsj.com

DMK Pharmaceuticals Corp.

September 28, 2023 | marketwatch.com

DMK Pharmaceuticals Shares More Than Double on Canada Patent for Opioid

See More Headlines

Receive DMK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DMK Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 12/02/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/21/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:DMK
CUSIP: N/A
CIK: 887247
Web: www.dmkpharmaceuticals.com
Phone: 858-997-2400
Fax: N/A
Employees: 11
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-26,480,000.00
Net Margins: -630.85%
Pretax Margin: -600.29%
Return on Equity: N/A
Return on Assets: -251.02%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.58
Quick Ratio: 0.54

Sales & Book Value

Annual Sales: $4.76 million
Price / Sales: 1.20
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.52) per share
Price / Book: -1.09

Miscellaneous

Outstanding Shares: 10,100,000
Free Float: 9,506,000
Market Cap: $5.73 million
Optionable: Not Optionable
Beta: 1.25

The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. David J. Marguglio (Age 53)
Co-Founder, President & COO
Comp: $526.35k
Dr. Ebrahim Versi M.D. (Age 70)
Ph.D., CEO & Chair of the Board
Mr. Seth Abraham Cohen (Age 60)
Chief Financial Officer
Mr. John W. Dorbin Jr. (Age 52)
General Counsel Corporate Secretary
Ms. Jennifer C. Suski
Senior Director of Marketing
Mr. Eddie Wabern Glover (Age 73)
Chief Executive Officer of US Compounding Inc
Mr. Robert B. Rothermel (Age 79)
Consultant
Comp: $41.81k

Key Competitors

View All Competitors

DMK Stock Analysis - Frequently Asked Questions

How have DMK shares performed in 2023?: DMK Pharmaceuticals' stock was trading at $0.6655 on January 1st, 2023. Since then, DMK stock has decreased by 14.7% and is now trading at $0.5677.
View the best growth stocks for 2023 here.
When is DMK Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024.
View our DMK earnings forecast.
How do I buy shares of DMK Pharmaceuticals?: Shares of DMK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:DMK) was last updated on 12/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial